A report on the anti-fibrotic effects of Corydalis saxicola Bunting (CS) using a combined metabolomic and network pharmacology approach suggests that chelerythrine and sanguinarine are potentially active compounds in CS for the treatment of liver fibrosis by modulating ALT activity [61]. The gene discussed is GPT; the disease is Hepatic fibrosis.